Foundry Partners’s Halozyme HALO Stock Holding History

Foundry Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-192,014	Closed	-$5.05M	–	429
2020 Q3	$5.05M	Sell	192,014 -2,909	-1%	-$81K	0.24%	129
2020 Q2	$5.23M	Buy	+194,923	New	+$4.4M	0.26%	130

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Foundry Partners's HALO Position: Q4 2020 in Review

Foundry Partners sold out of Halozyme (HALO) in Q4 2020, closing a stake of 192,014 shares — an estimated $5.05M sold.

Foundry Partners first reported a position in HALO in Q2 2020 and held it in 2 quarters. The position peaked at $5.23M in Q2 2020. 342 funds tracked by Wall St. Rank hold HALO as of Q4 2020.

Foundry Partners reported no remaining Halozyme position as of Q4 2020 after selling out during the quarter.
Foundry Partners sold 192,014 Halozyme shares in Q4 2020, an estimated $5.05M.
Foundry Partners first reported a position in Halozyme in Q2 2020 and held it in 2 quarters.
Foundry Partners's Halozyme position peaked at $5.23M in Q2 2020.
342 funds tracked by Wall St. Rank held Halozyme as of Q4 2020.

Based on Foundry Partners's 13F filing for Q4 2020, filed 4 Feb 2021.